Podcast: Improving Natural Language Processing Error Rates

Podcast

C. Matthew Hawkins, MD, discusses challenges of natural language processing and how more standardization can reduce error rates of speech recognition software.

[[{"type":"media","view_mode":"media_crop","fid":"11967","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_7562901937715","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"207","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: right; border-width: 0px; border-style: solid;","title":" ","typeof":"foaf:Image"}}]]As many as 22 percent of radiology reports contain errors associated with natural language processing, said C. Matthew Hawkins, MD, a pediatric radiology fellow at Cincinnati Children’s Hospital Medical Center. Hawkins is speaking on the topic at the SIIM 2012 conference in Orlando this week.

In this podcast, Hawkins discusses how these errors can change the meaning of radiology reports and how augmenting standardized content associated with various types of speech recognition software can decrease mistakes.  

Recent Videos
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
Related Content
FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl

FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl

Jeff Hall
June 25th 2025
Article

Expanded indications for the flutemetamol F18 injection include amyloid quantification and monitoring of anti-amyloid treatments.

The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2

The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 2

Jeff Hall
May 5th 2025
Podcast

In a second part of a new podcast episode on recently published research on projected radiation-induced cancers from computed tomography (CT) scans, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., offer current perspectives on cardiac CT dosing, AI advances and the importance of teamwork in ensuring appropriate dosing for CT.

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

Jeff Hall
June 24th 2025
Article

The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.

The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 1

The Reading Room Podcast: Current Insights on Recent Research About Radiation-Induced Cancers with CT Scans, Part 1

Jeff Hall
May 2nd 2025
Podcast

In a new podcast, Mahadevappa Mahesh, MS, Ph.D., and Joseph Cavallo, M.D., share their perspectives on recently published research looking at projections for future radiation-induced cancers from computed tomography (CT) scans.

‘I’m Telling You for the Last Time’ (Said No Radiologist Who Was Ever Taken Seriously)

‘I’m Telling You for the Last Time’ (Said No Radiologist Who Was Ever Taken Seriously)

Eric Postal, MD
June 23rd 2025
Article

Whether it comes in the form of seemingly extraneous addendums or the need to emphasize key points in radiology reporting, repetition can be a constant source of frustration.

SNMMI: Preliminary Research Suggests Dual-Targeting Radiopharmaceutical May Have Impact in Multiple Cancers

SNMMI: Preliminary Research Suggests Dual-Targeting Radiopharmaceutical May Have Impact in Multiple Cancers

Jeff Hall
June 23rd 2025
Article

The dual-targeted 177Lu-DOTA-FAPI-RGD reportedly reduced or stopped the growth of cancer lesions in 88.9 percent of advanced adenocarcinomas in a small cohort of patients with varied cancers including pulmonary, pancreatic and ovarian cancer, according to new research presented at the SNMMI conference.

© 2025 MJH Life Sciences

All rights reserved.